Search for: "AMGEN INC."
Results 501 - 520
of 704
Sorted by Relevance
|
Sort by Date
12 Jan 2015, 10:24 am
Hernán Ayala, vicepresidente de operaciones de Luis Ayala Colón Sucrs, Inc.; Repte. [read post]
4 Oct 2012, 4:07 pm
” Amgen Inc. v. [read post]
24 Sep 2015, 4:00 am
Id. at 12-13 (citing Amgen Inc. v. [read post]
5 Feb 2007, 10:37 pm
Amgen, Inc., et al. (01/29/2007): appeal of summary judgment to bring patent case for lack of standing (plaintiff did not have sole ownership of the patent), discussion of patent relating to a protein used to treat rheumatoid arthritis (U.S. [read post]
4 Jun 2008, 8:32 pm
TNF blockers currently approved for pediatric use include etanercept (Enbrel, Immunex Corp, marketed by Amgen and Wyeth Pharmaceuticals), adalimumab (Humira, Abbott Laboratories), and infliximab (Remicade, Centocor, Inc). [read post]
27 Apr 2007, 12:04 pm
The Need for Independent PTO-Free Post-Grant Governance: The Amgen testimony implied a need for a very reliable post-grant system. [read post]
28 Sep 2016, 8:39 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
13 Oct 2016, 6:50 am
Amgen Inc., et al., No. 15-1039 (Does the notice requirement of the BPCIA create an effective six-month exclusivity post-FDA approval?) [read post]
25 Oct 2011, 12:23 pm
See Markman, 517 U.S. at 391; see also Amgen, Inc. v. [read post]
4 Aug 2010, 9:20 am
Cir. 1993); Amgen, Inc. v. [read post]
26 Nov 2015, 8:12 am
Per the precedent set in Kirin-Amgen Inc v Hoechst Marion Roussel Ltd [2004] UKHL 46 (and other cases since), the question is "...what the person skilled in the art would have understood the Patentee to be using the language of the claim to mean". [read post]
24 Feb 2015, 2:24 pm
Commentator Roberta Karmel noted that she had difficulty reconciling the Supreme Court’s decision in 2013 opinion in Amgen v. [read post]
26 Jul 2017, 3:49 am
As explained in paragraph 42 of this judgment, in paragraph 37 of Kirin-Amgen Inc v Hoechst Marion Roussel Ltd [2005] RPC 9, Lord Hoffmann explained that the doctrine of equivalents had been developed in the United States. [read post]
8 Mar 2010, 10:37 am
Amgen Inc., 475 F.3d 1256, 1264–65 (Fed. [read post]
16 Apr 2019, 6:54 pm
Amgen Inc., Case PGR2019-00001 (PTAB Feb. 14, 2019) (Paper 11) the Board granted Petitioners’ Motion to Update its Mandatory Notices before the institution of trial and denied Patent Owner’s request for permission to file a Motion for Discovery of facts surrounding a real party-in-interest (RPI) issue. [read post]
26 Feb 2014, 10:25 am
Justice Kennedy (and Justice Scalia) sat on the Court that handed down Basic, Inc. v. [read post]
26 Jul 2017, 3:49 am
As explained in paragraph 42 of this judgment, in paragraph 37 of Kirin-Amgen Inc v Hoechst Marion Roussel Ltd [2005] RPC 9, Lord Hoffmann explained that the doctrine of equivalents had been developed in the United States. [read post]
12 Mar 2012, 5:41 pm
Amgen, Inc. and Pfizer, Inc., No. 12-cv-01123 (E.D.N.Y., Mar. 7, 2012) (Complaint) Amer. [read post]
28 Jun 2016, 6:41 am
Amgen (BPCIA patent dance). [read post]
23 Jan 2018, 7:29 pm
Amgen. [read post]
